Schonfeld Strategic Advisors LLC - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 74 filers reported holding ADMA BIOLOGICS INC in Q3 2019. The put-call ratio across all filers is 3.79 and the average weighting 0.6%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q2 2023$106,400
-69.8%
28,835
-72.9%
0.00%
-66.7%
Q1 2023$352,011
-74.9%
106,348
-70.6%
0.00%
-75.0%
Q4 2022$1,404,998
-31.1%
362,113
-56.8%
0.01%
-29.4%
Q3 2022$2,038,000
-2.8%
838,466
-20.8%
0.02%
-15.0%
Q2 2022$2,096,000
-7.6%
1,058,641
-14.6%
0.02%0.0%
Q1 2022$2,269,000
+136.4%
1,239,656
+82.1%
0.02%
+122.2%
Q4 2021$960,000
+1016.3%
680,684
+795.6%
0.01%
+800.0%
Q3 2021$86,000
-87.8%
76,000
-82.8%
0.00%
-87.5%
Q2 2021$707,000
-42.0%
441,873
-36.2%
0.01%
-46.7%
Q1 2021$1,219,000
+9.0%
692,287
+20.7%
0.02%0.0%
Q4 2020$1,118,000
-36.0%
573,573
-21.6%
0.02%
-54.5%
Q3 2020$1,748,000
-49.2%
731,723
-37.7%
0.03%
-28.3%
Q2 2020$3,440,000
+65.1%
1,173,834
+62.3%
0.05%
-64.9%
Q1 2020$2,083,000
-58.0%
723,427
-41.7%
0.13%
+8.3%
Q4 2019$4,963,000
-29.0%
1,240,793
-21.0%
0.12%
-41.0%
Q3 2019$6,988,000
-16.7%
1,570,408
-27.5%
0.20%
-30.7%
Q2 2019$8,384,000
+882.9%
2,166,400
+862.8%
0.30%
+886.7%
Q1 2019$853,000225,0000.03%
Other shareholders
ADMA BIOLOGICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Velan Capital Investment Management LP 4,000,000$15,520,00013.71%
Stonepine Capital Management, LLC 6,940,000$26,927,20011.33%
Caligan Partners LP 2,676,093$10,383,2418.64%
Altium Capital Management LP 2,870,000$11,135,6005.66%
AWM Investment Company, Inc. 6,015,000$23,338,2003.36%
EAM Investors, LLC 1,749,598$6,788,4401.40%
Perceptive Advisors 11,900,255$46,172,9891.30%
EAM Global Investors LLC 836,323$3,244,9330.84%
Potomac Capital Management, Inc. 120,000$4660.54%
OBERWEIS ASSET MANAGEMENT INC/ 536,900$2,083,1720.44%
View complete list of ADMA BIOLOGICS INC shareholders